Among the seven genes in the GO BP category “neutrophil activation involved in immune response” (Supplementary Fig. S11), three were already identified as COVID-19 biomarkers: CEACAM8 (alias CD66B), that codes for a neutrophil cell-adhesion protein and is highly expressed in patients with severe COVID-1973. The gene discussed is CEACAM8; the disease is COVID-19.